Sage Journals: Discover world-class research

Abstract

Keratocystic odontogenic tumors (KCOTs, previously known as odontogenic keratocysts) are aggressive jaw lesions that may occur in isolation or in association with nevoid basal cell carcinoma syndrome (NBCCS). Mutations in the PTCH1 (PTCH) gene are responsible for NBCCS and are related in tumors associated with this syndrome. Mutations in the SMO gene have been identified in basal cell carcinoma and in medulloblastoma, both of which are features of NBCCS. To clarify the role of PTCH1 and SMO in KCOTs, we undertook mutational analysis of PTCH1 and SMO in 20 sporadic and 10 NBCCS-associated KCOTs, and for SMO, 20 additional cases of KCOTs with known PTCH1 status were also included. Eleven novel (1 of which occurred twice) and 5 known PTCH1 mutations were identified. However, no pathogenic mutation was detected in SMO. Our findings suggest that mutations are rare in SMO, but frequent in PTCH1 in sporadic and NBCCS-associated KCOTs. Abbreviations: NBCCS, nevoid basal cell carcinoma syndrome; KCOTs, keratocystic odontogenic tumors; BCCs, basal cell carcinomas.

Get full access to this article

View all access options for this article.

References

Barreto DC, Gomez RS, Bale AE, Boson WL, De Marco L -2000-. PTCH gene mutations in odontogenic keratocysts. J Dent Res 79:1418–1422.

Boutet N, Bignon YJ, Drouin-Garraud V, Sarda P, Longy M, Lacombe D, et al. -2003-. Spectrum of PTCH1 mutations in French patients with Gorlin syndrome. J Invest Dermatol 121:478–481.

Browne RM -1971-. The odontogenic keratocyst. Histological features and their correlation with clinical behaviour. Br Dent J 131:249–259.

D’Errico M, Calcagnile A, Canzona F, Didona B, Posteraro P, Cavalieri R, et al. -2000-. UV mutation signature in tumor suppressor genes involved in skin carcinogenesis in xeroderma pigmentosum patients. Oncogene 19:463–467.

Gailani MR, Stahle-Backdahl M, Leffell DJ, Glynn M, Zaphiropoulos PG, Pressman C, et al. -1996-. The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet 14:78–81.

Gorlin RJ -1987-. Nevoid basal-cell carcinoma syndrome. Medicine -Baltimore- 66:98–113.

Gu XM, Zhao HS, Sun LS, Li TJ -2006-. PTCH mutations in sporadic and Gorlin-syndrome-related odontogenic keratocysts. J Dent Res 85:859–863.

Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A, et al. -1996-. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85:841–851.

Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, et al. -1996-. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272:1668–1671.

10.

Kimonis VE, Goldstein AM, Pastakia B, Yang ML, Kase R, DiGiovanna JJ, et al. -1997-. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 69:299–308.

11.

Kogerman P, Krause D, Rahnama F, Kogerman L, Unden AB, Zaphiropoulos PG, et al. -2002-. Alternative first exons of PTCH1 are differentially regulated in vivo and may confer different functions to the PTCH1 protein. Oncogene 21:6007–6016.

12.

Lench NJ, Telford EA, High AS, Markham AF, Wicking C, Wainwright BJ -1997-. Characterisation of human patched germ line mutations in naevoid basal cell carcinoma syndrome. Hum Genet 100:497–502.

13.

Levanat S, Gorlin RJ, Fallet S, Johnson DR, Fantasia JE, Bale AE -1996-. A two-hit model for developmental defects in Gorlin syndrome. Nat Genet 12:85–87.

14.

Li TJ, Browne RM, Matthews JB -1994-. Quantification of PCNA+ cells within odontogenic jaw cyst epithelium. J Oral Pathol Med 23:184–189.

15.

Lindstrom E, Shimokawa T, Toftgard R, Zaphiropoulos PG -2006-. PTCH mutations: distribution and analyses. Hum Mutat 27:215–219.

16.

Nagao K, Toyoda M, Takeuchi-Inoue K, Fujii K, Yamada M, Miyashita T -2005a-. Identification and characterization of multiple isoforms of a murine and human tumor suppressor, patched, having distinct first exons. Genomics 85:462–471.

17.

Nagao K, Togawa N, Fujii K, Uchikawa H, Kohno Y, Yamada M, et al. -2005b-. Detecting tissue-specific alternative splicing and disease-associated aberrant splicing of the PTCH gene with exon junction microarrays. Hum Mol Genet 14:3379–3388.

18.

Ohki K, Kumamoto H, Ichinohasama R, Sato T, Takahashi N, Ooya K -2004-. PTC gene mutations and expression of SHH, PTC, SMO, and GLI-1 in odontogenic keratocysts. Int J Oral Maxillofac Surg 33:584–592.

19.

Pastorino L, Cusano R, Nasti S, Faravelli F, Forzano F, Baldo C, et al. -2005-. Molecular characterization of Italian nevoid basal cell carcinoma syndrome patients. Hum Mutat 25:322–323.

20.

Pavelic B, Levanat S, Crnic I, Kobler P, Anic I, Manojlovic S, et al. -2001-. PTCH gene altered in dentigerous cysts. J Oral Pathol Med 30:569–576.

21.

Pruvost-Balland C, Gorry P, Boutet N, Magnaldo T, Mamelle G, Margulis A, et al. -2006-. Clinical and genetic study in 22 patients with basal cell nevus syndrome. Ann Dermatol Venereol 133:117–123.

22.

Raffel C, Jenkins RB, Frederick L, Hebrink D, Alderete B, Fults DW, et al. -1997-. Sporadic medulloblastomas contain PTCH mutations. Cancer Res 57:842–845.

23.

Reifenberger J, Wolter M, Weber RG, Megahed M, Ruzicka T, Lichter P, et al. -1998-. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 58:1798–1803.

24.

Smyth I, Wicking C, Wainwright B, Chenevix-Trench G -1998-. The effects of splice site mutations in patients with naevoid basal cell carcinoma syndrome. Hum Genet 102:598–601.

25.

Stone DM, Hynes M, Armanini M, Swanson TA, Gu Q, Johnson RL, et al. -1996-. The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog. Nature 384:129–134.

26.

Teh MT, Blaydon D, Chaplin T, Foot NJ, Skoulakis S, Raghavan M, et al. -2005-. Genomewide single nucleotide polymorphism microarray mapping in basal cell carcinomas unveils uniparental disomy as a key somatic event. Cancer Res 65:8597–8603.

27.

Toftgard R -2000-. Hedgehog signalling in cancer. Cell Mol Life Sci 57:1720–1731.

28.

Wicking C, Shanley S, Smyth I, Gillies S, Negus K, Graham S, et al. -1997-. Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident. Am J Hum Genet 60:21–26.

29.

Wolter M, Reifenberger J, Sommer C, Ruzicka T, Reifenberger G -1997-. Mutations in the human homologue of the Drosophila segment polarity gene patched -PTCH- in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 57:2581–2585.

30.

Xie J, Murone M, Luoh SM, Ryan A, Gu Q, Zhang C, et al. -1998-. Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 391:90–92.

31.

Yuan JW, Li TJ, Zhong HH, Zhao HS -2006-. PTCH gene mutations in odontogenic keratocysts. Zhonghua Kou Qiang Yi Xue Za Zhi 41:41–44.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.52 MB

PTCH1 and SMO Gene Alterations in Keratocystic Odontogenic Tumors

Abstract

Get full access to this article

References

Supplementary Material